Skip to content

CANDY MULTIPLEX STUDY

CANDY MULTIPLEX STUDY - Multiplex

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52192
Enrollment
100
Registered
2022-01-12
Start date
2023-06-05
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorder

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 64 Years

Inclusion criteria

Inclusion criteria: Multiplex (MPX) families will be enrolled when there are at least two diagnosed individuals, one with ASD, and at least one other first or second-order member with epilepsy, ASD, ID or ADHD (age 3 years and older). All unaffected first-degree relatives of an MPX family will be invited to participate as well.

Exclusion criteria

Exclusion criteria: None of the biological parents of the ASD proband is available / willing to participate

Design outcomes

Primary

MeasureTime frame
1) Complete genetic profile of all participants (including rare and common genes). 2) Refined phenoptyping of all participants by means of questionnaires and interviews in terms of: ASD symptoms and traits, Cognitive and neurocognitive level, Developmental level, Somatic comorbidities (clinical epilepsy, allergies, immune disease, gastro-intestinal problems) and Psychiatric comorbidities. A subsample of the participants will be invited for a nested follow-up study with assessment of EEG/ERP, eye-tracking and cognition; for this, we will submit an amendment at due time.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)